4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-023865
EVP, COO, Head of Commercial sold 1,751 shares at $18.16 ($31,798)
- EVP, COO, Head of Commercial acquired 5,024 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2023-04-05 | Option exercise | +5,024 | 10,219 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-04-06 | Sale | −1,751 | $18.16 | $31,798 | 8,468 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-04-05 | Option exercise · Restricted Stock Units | −5,024 | 15,072 | D | ||
| Open-market sales · 1,751 sh · avg $18.16 · $31,798 | |||||||
Loading xslF345X04/doc4.xml…